US 10517869
Topical brimonidine tartrate ophthalmic solution
granted A61KA61K31/498A61K47/02
Quick answer
US patent 10517869 (Topical brimonidine tartrate ophthalmic solution) held by SENTISS PHARMA PRIVATE LIMITED expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTISS PHARMA PRIVATE LIMITED
- Grant date
- Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/498, A61K47/02, A61K47/186, A61K47/38